SwePub
Sök i LIBRIS databas

  Extended search

L773:1872 7549 OR L773:0166 4328
 

Search: L773:1872 7549 OR L773:0166 4328 > Intranasal administ...

Intranasal administration of alpha-synuclein aggregates : a Parkinson's disease model with behavioral and neurochemical correlates

Gruden, Marina A (author)
Davydova, Tatiana V (author)
Narkevich, Victor B (author)
show more...
Fomina, Valentina G (author)
Wang, Chao (author)
Umeå universitet,Institutionen för medicinsk kemi och biofysik
Kudrin, Vladimir S (author)
Morozova-Roche, Ludmilla A (author)
Umeå universitet,Institutionen för medicinsk kemi och biofysik
Sewell, Robert DE (author)
show less...
 (creator_code:org_t)
Elsevier, 2014
2014
English.
In: Behavioural Brain Research. - : Elsevier. - 0166-4328 .- 1872-7549. ; 263, s. 158-168
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Parkinson's disease (PD) is a neurodegenerative disorder in which both alpha-synuclein (alpha-syn) and dopamine (DA) have a critical role. Our previous studies instigated a novel PD model based on nasal inoculation with alpha-syn aggregates which expressed parkinsonian-like behavioral and immunological features. The current study in mice substantiated the robustness of the amyloid nasal vector model by examining behavioral consequences with respect to DA-ergic neurochemical corollaries. In vitro generated alpha-syn oligomers and fibrils were characterized using atomic force microscopy and the thioflavin T binding assay. These toxic oligomers or fibrils administered alone (0.48 mg/kg) or their 50:50 combination (total dose of 0.48 mg/kg) were given intranasally for 14 days and "open-field" behavior was tested on days 0, 15 and 28 of the protocol. Behavioral deficits at the end of the 14-day dosing regime and on day 28 (i.e., 14 days after treatment completion) induced rigidity, hypokinesia and immobility. This was accompanied by elevated nigral but not striatal DA, DOPAC and HVA concentrations in response to dual administration of alpha-syn oligomers plus fibrils but not the oligomers by themselves. alpha-Syn fibrils intensified not only the hypokinesia and immobility 14 days post treatment, but also reduced vertical rearing and enhanced DA levels in the substantia nigra. Only nigral DA turnover (DOPAC/DA but not HVA/DA ratio) was augmented in response to fibril treatment but there were no changes in the striatum. Compilation of these novel behavioral and neurochemical findings substantiate the validity of the alpha-syn nasal vector model for investigating parkinsonian-like symptoms.(C) 2014 Elsevier B.V. All rights reserved.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Medicinska och farmaceutiska grundvetenskaper -- Neurovetenskaper (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Basic Medicine -- Neurosciences (hsv//eng)
MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Neurologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Neurology (hsv//eng)

Keyword

Rodent model; α-synuclein oligomers; Fibrils; Behavior; Dopamine neurochemistry

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view